Stockscreener 앱 받기
15.04
4.99%
0.715
시간 외 거래:
15.34
0.30
+1.99%
Atara Biotherapeutics Inc 주식(ATRA)의 최신 뉴스
How Atara Biotherapeutics Inc. stock reacts to global recession fearsJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com
How to use Fibonacci retracement on Atara Biotherapeutics Inc.Buy Signal & Fast Gain Swing Alerts - newser.com
Will Atara Biotherapeutics Inc. stock maintain growth storyMarket Risk Analysis & Consistent Return Strategy Ideas - newser.com
Volume spikes in Atara Biotherapeutics Inc. stock – what they meanMarket Sentiment Review & Weekly Hot Stock Watchlists - newser.com
Can you recover from losses in Atara Biotherapeutics Inc.July 2025 Movers & Comprehensive Market Scan Insights - newser.com
Chart based exit strategy for Atara Biotherapeutics Inc.Market Activity Summary & Safe Investment Capital Preservation Plans - newser.com
Using economic indicators to assess Atara Biotherapeutics Inc. potentialJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Will Atara Biotherapeutics Inc. continue its uptrendWeekly Risk Summary & Precise Buy Zone Tips - newser.com
What hedge fund activity signals for Atara Biotherapeutics Inc. stockJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
How rising interest rates impact Atara Biotherapeutics Inc. stockRisk Management & Free Technical Confirmation Trade Alerts - newser.com
Atara Biotherapeutics' (ATRA) "Sell (D+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Stock Catapults 30% Though Its Price And Business Still Lag The Industry - simplywall.st
Atara Biotherapeutics Inc. stock trendline breakdownQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Statistical indicators supporting Atara Biotherapeutics Inc.’s strengthJuly 2025 Rallies & Verified Momentum Stock Ideas - newser.com
Pattern recognition hints at Atara Biotherapeutics Inc. upside2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Atara Biotherapeutics Inc Stock Analysis and ForecastAutomated Trading Signals & Your Free Entry to Smart Investing Starts Here - earlytimes.in
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives $21.00 Consensus Price Target from Brokerages - Defense World
How Atara Biotherapeutics Inc. (AT20) stock stacks up against competitorsNew Guidance & Real-Time Market Trend Scan - newser.com
Is Atara Biotherapeutics Inc. stock positioned for long term growthPortfolio Value Report & Expert Verified Stock Movement Alerts - newser.com
What drives Atara Biotherapeutics Inc stock priceStock Price Divergence & Low Entry Capital Stocks - earlytimes.in
Can swing trading help recover from Atara Biotherapeutics Inc. losses2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Pancreatic Cancer Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Bio, Keymed Biosciences, Carisma Therapeu - Barchart.com
While institutions own 28% of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), individual investors are its largest shareholders with 35% ownership - Yahoo Finance
Cancer stocks rebound, outpacing broader markets in Q3 2025 - BioWorld MedTech
Analyzing net buyer seller activity in Atara Biotherapeutics Inc.Quarterly Investment Review & Reliable Volume Spike Alerts - newser.com
4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals - inkl
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates - MSN
1.11%
자본화:
|
볼륨(24시간):